We are live on
!
Find out more
SIP
Stoneridge Investment Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
7.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.03%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$238M
AUM Growth
+$25.7M
(+12%)
Cap. Flow
+$5.05M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
116
New
16
Increased
25
Reduced
31
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$5.97M |
| 2 |
TJX Companies
TJX
|
+$4.98M |
| 3 |
Pfizer
PFE
|
+$4.01M |
| 4 |
Chubb
CB
|
+$2.74M |
| 5 |
Procter & Gamble
PG
|
+$2.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$6.34M |
| 2 |
W.R. Berkley
WRB
|
+$3.36M |
| 3 |
Dollar Tree
DLTR
|
+$3.31M |
| 4 |
Regions Financial
RF
|
+$2.99M |
| 5 |
Keurig Dr Pepper
KDP
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.3% |
| 2 | Financials | 12.53% |
| 3 | Healthcare | 12.28% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 8.65% |
Similar funds
DW
PF
AFW
RC
CPW
SMA
LDNAM
MFF
Stoneridge Investment Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Stoneridge Investment Partners held 116 positions worth $238M, up 12% from $212M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Stoneridge Investment Partners's Q4 2023 filing shows 16 new, 25 increased, 31 reduced and 25 closed positions. Its largest new stake was Biogen: 24,322 shares worth $6.29M. The largest sale was CVS Health, an estimated $6.34M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- Stoneridge Investment Partners's largest Q4 2023 buy was Biogen: 24,322 shares worth $6.29M.
- Stoneridge Investment Partners added most to Pfizer in Q4 2023, an estimated $4.01M increase.
- Stoneridge Investment Partners's biggest Q4 2023 reduction was Salesforce, cutting an estimated $2.42M.
- Stoneridge Investment Partners fully exited CVS Health in Q4 2023, selling an estimated $6.34M.
- Stoneridge Investment Partners's ten largest holdings make up 35% of its $238M portfolio in Q4 2023.
- Stoneridge Investment Partners opened 16 new positions and closed 25 in Q4 2023.
- Stoneridge Investment Partners's portfolio value rose 12% quarter-over-quarter to $238M.
Based on Stoneridge Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.